• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Repare Therapeutics Inc (NQ: RPTX )

    3.490 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Repare Therapeutics Inc

    < Previous 1 2 3 4 5 6 Next >
    Repare Therapeutics Reports Proof of Concept for Lunresertib (RP-6306) in Clinic, Initial Monotherapy Data from Phase 1 MYTHIC Clinical Trial and Early Insights from Ongoing Combination Trials
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Announces Publication in Nature Medicine Highlighting Clinical Benefit of Camonsertib in Advanced Solid Tumors
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics to Host Conference Call and Webcast to Discuss Initial RP-6306 Monotherapy Data from Phase 1 MYTHIC Clinical Trial and Early Combination Trials Insights
    From Repare Therapeutics Inc.
    Via Business Wire
    Recap: Repare Therapeutics Q1 Earnings
    Via Benzinga
    Analyst Expectations for Repare Therapeutics's Future
    Via Benzinga
    4 Analysts Have This to Say About Repare Therapeutics
    Via Benzinga
    Repare Therapeutics's Return On Capital Employed Insights
    Via Benzinga
    Repare Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Appoints Susan Molineaux, Ph.D., to Its Board of Directors
    From Repare Therapeutics Inc.
    Via Business Wire
    NASDAQ: RPTX Investor Alert: Investigation over Potential Wrongdoing at Repare Therapeutics Inc.
    San Diego, CA -- (SBWIRE) -- 04/28/2023 -- Certain directors of Repare Therapeutics Inc. are under investigation over potential breaches of fiduciary duties. 
    Via SBWire
    Repare Therapeutics Presents Initial Clinical Data from the Phase 1/2 TRESR and ATTACC Trials Evaluating Camonsertib in Combination with Three PARP Inhibitors at the 2023 AACR Annual Meeting
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Announces Plenary Oral Presentation at the 2023 AACR Annual Meeting on Camonsertib and Additional Data Presentations on RP-6306
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Inc. (NASDAQ:RPTX) Investor Investigation over Possible Violations of Securities Laws
    San Diego, CA -- (SBWIRE) -- 02/22/2023 -- An investigation shares over potential securities laws violations by Repare Therapeutics Inc. 
    Via SBWire
    Cathie Wood Has Been Building Stakes In Two Little-Known Stocks
    Cathie Wood – the billionaire investor who recently called her flagship fund “the new Nasdaq” has been loading up on shares of the following two small-cap stocks in recent days. 
    Via Talk Markets
    Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Repare Therapeutics Inc. (RPTX) Investigation
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
    Via Benzinga
    Repare Therapeutics to Participate in Two Upcoming Investor Conferences
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Receives $1.5 Million (¥200 million) Payment from Ono Pharmaceuticals
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans
    From Repare Therapeutics Inc.
    Via Business Wire
    Credit Suisse, Autodesk And Other Big Losers From Wednesday
    U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
    Via Benzinga
    Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday
    Via Benzinga
    Repare Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics to Participate in Two Upcoming Investor Conferences
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics to Participate in Two Upcoming Investor Conferences
    From Repare Therapeutics Inc.
    Via Business Wire
    Repare Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
    From Repare Therapeutics Inc.
    Via Business Wire
    Biotech ETF Tops in June: 5 Stocks That Outperform
    Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%. 
    Via Talk Markets
    The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    United Airlines And 3 Other Stocks Insiders Are Buying
    Although US stocks closed slightly higher on Monday, there were a few notable insider trades. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.